Ingested IFNα given at 5,000 IU daily for a year stabilized B-cell function in children with new onset type 1 diabetes significantly (P < 0.028) better than placebo or 30,000 IU IFNα daily [119]. The gene discussed is IFNA1; the disease is type 1 diabetes mellitus.